Cargando…
MiR-223 or miR-126 predicts resistance to dual antiplatelet therapy in patients with ST-elevation myocardial infarction
OBJECTIVE: To explore the role of miR-223 and miR-126 in predicting treatment responses to dual antiplatelet therapy (DAPT) in patients with ST-elevation myocardial infarction (STEMI). METHODS: Plasma miR-223 and miR-126 levels were measured before treatment. Treatment responses and 2-year survival...
Autores principales: | Li, Xiaojing, Yao, Qi, Cui, Hanbin, Yang, Jun, Wu, Nan, Liu, Yahui, Zhou, Ying, Zhang, Yinwei, Su, Jia, Xia, Yezi, Chen, Xiaomin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191085/ https://www.ncbi.nlm.nih.gov/pubmed/34098766 http://dx.doi.org/10.1177/03000605211016209 |
Ejemplares similares
-
Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
por: Fourdinier, Ophélie, et al.
Publicado: (2019) -
miR-126 and miR-126*: New Players in Cancer
por: Meister, Jeannette, et al.
Publicado: (2010) -
MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty
por: Hromadka, Milan, et al.
Publicado: (2021) -
The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy
por: Shi, Rui, et al.
Publicado: (2015) -
MiR-223 and MiR-186 Are Associated with Long-Term Mortality after Myocardial Infarction
por: Elbaz, Meyer, et al.
Publicado: (2022)